Furthermore, combining SPINT1 with other biomarkers (including those that are yet to be reported) or with ultrasound findings at different gestations may yield a highly accurate diagnostic test of fetal growth restriction and placental insufficiency. The gene discussed is SPINT1; the disease is fetal growth restriction.